ATAI Competitors & Alternatives
Compare ATAI Life Sciences BV with similar stocks in the same industry
Biotechnology
ATAI
Main Stock$7.35
Tradestie Score
44
Market Cap
$1.22B
Revenue Growth
1.4%
Analyst Upside
+10.2%
Top Competitors
221 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CGON
CG Oncology, Inc. Common stock
|
$61.16
|
$3.01B | - | 64 | Compare |
|
APLS
Apellis Pharmaceuticals, Inc. Common Stock
|
$41.03
|
$2.92B | 38.3 | 50 | Compare |
|
RARE
Ultragenyx Pharmaceutical Inc.
|
$15.73
|
$2.89B | - | 40 | Compare |
|
IMVT
Immunovant, Inc. Common Stock
|
$28.55
|
$2.85B | - | 56 | Compare |
|
CPRX
Catalyst Pharmaceutical Inc.
|
$31.49
|
$2.56B | 18.2 | 51 | Compare |
|
CDTX
Cidara Therapeutics, Inc.
|
$221.38
|
$2.44B | - | 50 | Compare |
|
BEAM
Beam Therapeutics Inc. Common Stock
|
$23.75
|
$2.44B | - | 46 | Compare |
|
TARS
Tarsus Pharmaceuticals, Inc. Common Stock
|
$68.88
|
$2.42B | - | 61 | Compare |
|
BLTE
Belite Bio, Inc American Depositary Shares
|
$146.90
|
$2.41B | - | 60 | Compare |
|
IDYA
IDEAYA Biosciences, Inc. Common Stock
|
$35.01
|
$2.40B | - | 60 | Compare |
More ATAI Analysis
Data updated: Oct 23, 2026 | Industry: Biotechnology (SIC 2834)
221 stocks in this industry